Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Companies Breaking news CVS Health Corp
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
Tags Pharmaceuticals Health care industry Novo Nordisk A/S
From CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
Tags Obesity Pharmaceuticals Health & Science
From CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
Tags Investing Obesity Markets
From CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Tags Business News Pharmaceuticals Biotechnology
From CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
Tags Novo Nordisk A/S Markets Eaton Corporation PLC
From CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
Tags Business News Novo Nordisk A/S Breaking News: Business
From CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
Tags Pharmaceuticals Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
Tags Europe News Tesla Inc Breaking News: Markets
From CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
Tags Investing Markets Novo Nordisk A/S
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
Tags Business News Health care industry Biotechnology
From CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
Tags U/S/ Markets Business Investment Strategy
From CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Tags Biotech and Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
Tags Goldman Sachs Group Inc Goldman Sachs BDC Inc FactSet Research Systems Inc
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Eli Lilly and Co Earnings Salesforce Inc
From CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
Tags Walt Disney Co Europe Markets Moody's Corp
From CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
Tags Europe Markets Walt Disney Co Eli Lilly and Co
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Eli Lilly and Co Medifast Inc Herbalife Ltd
From CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Health Care IT Zoetis Inc Cats
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Zealand Pharma A/S UnitedHealth Group Inc Healthy Returns
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags Breaking News: Business Investment strategy ASML Holding NV
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Novo Nordisk A/S Breaking News: Markets Zealand Pharma A/S
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Employee benefits Weight management Labor economy
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags Weight management Business News Catalent Inc
From CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Tags Business News Health care industry Biotechnology
From CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Tags Novo Nordisk A/S Biotechnology Health care industry
From CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
Tags Health & Science Markets Earnings
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Advanced Micro Devices Inc United Parcel Service Inc Amazon/com Inc
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Biotech and Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Novo Nordisk A/S Biotechnology Pharmaceuticals
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.